Joseph Rakow Net Worth

The estimated Net Worth of Joseph Rakow is at least $678 Тысяча dollars as of 13 March 2024. Joseph Rakow owns over 3,546 units of Exponent stock worth over $370,876 and over the last few years Joseph sold EXPO stock worth over $307,432.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Joseph Rakow EXPO stock SEC Form 4 insiders trading

Joseph has made over 3 trades of the Exponent stock since 2023, according to the Form 4 filled with the SEC. Most recently Joseph sold 1,971 units of EXPO stock worth $187,245 on 7 May 2024.

The largest trade Joseph's ever made was exercising 3,546 units of Exponent stock on 13 March 2024 worth over $370,876. On average, Joseph trades about 1,726 units every 91 days since 2023. As of 13 March 2024 Joseph still owns at least 3,546 units of Exponent stock.

You can see the complete history of Joseph Rakow stock trades at the bottom of the page.

Insiders trading at Exponent

Over the last 21 years, insiders at Exponent have traded over $73,571,565 worth of Exponent stock and bought 2,000 units worth $170,360 . The most active insiders traders include Paul R Johnston, Richard L Jr Schlenker и John B Shoven. On average, Exponent executives and independent directors trade stock every 11 days with the average trade being worth of $675,547. The most recent stock trade was executed by Richard L Jr Schlenker on 31 July 2024, trading 40,662 units of EXPO stock currently worth $4,339,042.

What does Exponent do?

exponent is an engineering and scientific consulting firm providing solutions to complex problems. whether the firm investigates an incident that happened in the past, or assists with the development of a new product or service, exponent offers knowledge to assist its clients make informed, intelligent decisions. exponent's multidisciplinary organization of scientists, physicians, engineers, and business consultants brings together more than 90 technical disciplines to address complicated issues facing industry and business today. the firm's consultants analyze failures and accidents to determine their causes and provide answers to help prevent such problems. in addition, exponent evaluates human health and environmental concerns to find cost-effective solutions. exponent’s staff of approximately 900, located in 20 offices throughout the nation and 6 international offices, combines unparalleled technical expertise with the ability, when necessary, to focus this knowledge in extreme

Complete history of Joseph Rakow stock trades at Exponent

Exponent executives and stock owners

Exponent executives and other stock owners filed with the SEC include:

• Catherine Corrigan,
  President, Chief Executive Officer, Director
• Richard Schlenker,
  Chief Financial Officer, Executive Vice President, Corporate Secretary
• Dr. Catherine Ford Corrigan,
  Pres, CEO & Director
• Steven Murray,
  Group Vice President
• Sally Shepard,
  Chief Human Resource Officer
• Richard L. Schlenker Jr.,
  Exec. VP, CFO & Corp. Sec.
• Harri Kytomaa,
  Group Vice President
• Dr. Maureen T. F. Reitman Sc.D., F.S.P.E., P.E.,
  Corp. VP - Polymers Science & Materials Chemistry, Principal Engineer and Practice Director
• Dr. Steven J. Murray,
  Group VP & Principal Engineer
• Dr. Bradley A. James Ph.D., P.E., FASM,
  Corp. VP, Principal Engineer & Practice Director- Materials & Corrosion Engineering
• John Shoven,
  Lead Independent Director
• Debra Zumwalt,
  Independent Director
• Karen Richardson,
  Independent Director
• Carol Lindstrom,
  Independent Director
• Paul Johnston,
  Chairman of the Board
• George Brown,
  Director
• Maureen Reitman,
  Group Vice President
• Richard Reiss,
  Group Vice President
• John Pye,
  Group Vice President
• Brad James,
  Group Vice President
• Robert Haddad,
  Group Vice President
• Dr. Robert D. Caligiuri FASM, P.E., Ph.D.,
  Corp. VP of Materials & Corrosion Engineering and Principal Engineer
• Sally B. Shepard,
  Chief HR Officer
• Dr. Paul D. Boehm,
  Corp. VP of Environmental & Health Sciences and Principal Scientist
• Dr. Robert D. Caligiuri,
  Corp. VP of Materials & Corrosion Engineering and Principal Engineer
• Eric R. Anderson,
  VP & Corp. Controller
• Dr. Subbaiah V. Malladi,
  CTO & Principal Engineer
• Dr. Bernard Ross,
  Co-Founder, Chairman Emeritus & Principal Engineer
• Stephen C Riggins,
  Director
• John Osteraas,
  Group Vice President
• Paul Boehm,
  Group Vice President
• Robert D Caligiuri,
  Group Vice President
• John Joseph Doyle,
  Group Vice President
• Elizabeth L Anderson,
  Group Vice President
• Subbaiah V Malladi,
  Chief Technical Officer
• Leslie G Denend,
  Director
• Robert C Lange,
  Group Vice President
• John E Moalli,
  Group
• Samuel H Armacost,
  Director
• Jon R Katzenbach,
  Director
• Mary B Cranston,
  Director
• Michael R Gaulke,
  President & CEO
• Barbara M Barrett,
  Director
• Roger L Mccarthy,
  Chairman,
• Charles A Jr Rau,
  Corporate Vice President
• Larry W Anderson,
  Group Vice President
• Edward J Keith,
  Director
• Angela A Meyer,
  Vice President Client Services
• Piotr D Moncarz,
  Corporate Vice President
• Joseph Rakow,
  Group Vice President
• Eric Guyer,
  Group Vice Presient